期刊文献+

多肽诱导BALB/c小鼠自身免疫性心肌炎模型及鉴定 被引量:9

Producing and Evaluating a Model of Autoimmune Myocarditis in BALB/c Mouse Immunized with Peptide Antigen
下载PDF
导出
摘要 目的:以包含心肌球蛋白致病性抗原表位的人工合成多肽免疫BALB/c小鼠,建立实验性自身免疫性心肌炎动物模型。方法:FMOC法人工合成含心肌肌球蛋白抗原表位长度为14个氨基酸残基的多肽,经HPLC法纯化至纯度达95%以上并以质谱分析法鉴定。纯化多肽皮下免疫遗传易感BALB/c系小鼠,建立自身免疫性心肌炎模型。结果:88.9%(32/36)的实验组小鼠第14天出现心肌损伤,至第21天心肌损伤达高峰。心肌病理切片可见心肌层充血,间质单核细胞浸润明显并伴心肌细胞肿胀、坏死。血清抗心肌肌球蛋白自身抗体阳性,并伴肌钙蛋白I水平升高。结论:应用本方法可成功诱导BALB/c系小鼠发病,建立实验性自身免疫性心肌炎动物模型。 Objective: To establish animal model of experimental autoimmune myocarditis with specific peptide derived from myocarditic epitopes in BALB/c mice. Methods: Peptide antigen was synthesized by method of standard FMOC chemistry, purified by HPLC and determined by mass spectrography, before it was used for immunization of genetically predisposed mice to provoke autoimmune myocarditis. Results: The inflammatory injury of myocardium began at the 14th day after the first immunization, and was maximal at the 21st day. Histopathological examination of cardiac tissue showed an obvious mononuclear cell infiltrate with myocyte necrosis. Increasing levels of heart muscle specific autoantibody and cardiac troponin I were detectable in serum. Conclusion. This specific peptide can successfully induce autoimmune myocarditis in BALB/c mice.
出处 《武汉大学学报(医学版)》 CAS 2006年第2期206-209,i0003,共5页 Medical Journal of Wuhan University
关键词 心肌炎 自身免疫 动物模型 Myocarditis Autoimmune Animal Model
  • 相关文献

参考文献10

  • 1Nugent AW, Daubeney PE, Chondros P,et al. The epidemiology of childhood cardiomyopathy in Australia[J]. N Engl J Med,2003,348(17):l 639-1 646.
  • 2蔡刚,张军,刘莉,沈茜.腺病毒介导反义CⅡTA基因对实验性自身免疫性心肌炎的治疗[J].中华微生物学和免疫学杂志,2005,25(1):56-61. 被引量:2
  • 3Eriksson U, Bachmaier K, Penninger JM, et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity[J].Nat Med,2003,9(12):1 484-1 490.
  • 4Frustaci A, Cuoco L, Chimenti C, et al. Celiac disease associated with autoimmune myocarditis[J]. Circulation,2002,105(22) :2 611-2 618.
  • 5Frustaci A, Chimenti C, Calabrese F, et al. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders[J]. Circulation,2003,107(6) :857-863.
  • 6Bachmaier K, Neu N, Penninger JM,et al. Generation of humanized mice susceptible to peptide-induced inflammatory heart disease [J]. Circulation, 1999, 99(14):1 885-1 891.
  • 7Kohno K, Takagaki Y, Nakajima Y,et al. Advantage of recombinant technology for the identification of cardiac myosin epitope of severe autoimmune myocarditis in Lewis rats[J]. Jpn Heart J,2000,41(1) :67-77.
  • 8Kohno K, Takagaki Y, Aoyama N, et al. A peptide fragment of beta cardiac myosin heavy chain (beta-CMHC) can provoke autoimmune myocarditis as well as the corresponding alpha cardiac myosin heavy chain (alpha-CMHC) fragment [J]. Autoimmunity, 2001, 34(3) :177-185.
  • 9Galvin JE, Hemric ME, Kosanke SD,et al. Induction of myocarditis and valvulitis in lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis[J]. Am J Pathol, 2002,160 ( 1 ) : 297-306.
  • 10Li Y, Heuser JS, Kosanke SD,et al. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis Rat[J]. The Journal of Immunology,2004, 172(5): 3 225-3 234.

二级参考文献10

  • 1Conant SB, Swanborg RH. Application of tetramer technology in studies on autoimmune diseases. Autoimmun Rev, 2003, 2(1): 43-49.
  • 2Chinen J, Shearer WT. Basic and clinical immunology. J Allergy Clin Immunol, 2003, 111(3 Suppl): S813-818.
  • 3Izumi T, Kohno K, Inomata T, et al. Myocantitogenic epitopes and autoimmune myocarditis, Intern Med, 2003, 42( 1 ) : 3-6.
  • 4Chang CHI Flavell RA. Class Ⅱ transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med, 1995, 181(2) : 765-767.
  • 5Hake SB, Tobin HM, Steimle V, et al. Comparison of the transcriptional regulation of classical and non-classical MHC class Ⅱ genes. Eur J Immunol, 2003, 33(9): 2361-2371.
  • 6Godsel LM, Wang K, Schodin BA, et al. Prevention of autoimmune myocarditis through the induction of antigen-specific peripheral immune tolerance. Circulation, 2001, 27, 103 (12): 1709-1714.
  • 7Murakami U, Uchida K, Hiratsuka T. Cardiac myosin from pig heart ventricle: purification and enzymatic properties. J Biochem(Tokyo),1976, 80(3): 611-619.
  • 8el-Khatib MR, Chason JL, Silberberg B, et al. Coxsachievirus B4 myocarditis in mice: valvular changes in virus-infected and control animals. J Infect Dis, 1978, 137: 410-420.
  • 9Kishimoto C, Shioji K, Kineshita M, et al. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress, Int J Cardiol, 2003, 91(2-3): 173-178.
  • 10Wierda WG, Cantwell MJ, Woods SJ, et al. CD40-ligand (CD154)gene therapy for chronic lymphocytic leukemia. Blood, 2000, 96 (9):2917-2924.

共引文献1

同被引文献126

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部